Also published in GlobeNewswire:
Diverse Slate of Corporate Directors Become NACD Fellows - GlobeNewswire
x hide permanently

Prevail Therapeutics Announces Appointment of William H. Carson, M.D., to Board of Directors

GlobeNewswire

NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases, today announced the appointment of William H. Carson, M.D., to its Board of Directors...

Mentions: Nasdaq Prevail Therapeutics Inc Board